Vascular News and Research

RSS

Consistent glycaemic control wards off diabetic complications

Variability in glycaemic control is associated with both microvascular and macrovascular events in patients with Type 2 diabetes, shows an analysis of the ADVANCE trial.

23 May 2014

Experts discuss potential advantages of bioresorbable vascular scaffolds at EuroPCR 2014

At EuroPCR 2014 yesterday, experts discussed the development in evidence for bioresorbable vascular scaffolds, which represent an era of vascular restoration in interventional cardiology.

23 May 2014

Researchers identify chemical signals that promote breast cancer metastasis

Working with mice, Johns Hopkins researchers report they have identified chemical signals that certain breast cancers use to recruit two types of normal cells needed for the cancers' spread.

23 May 2014

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Alzheimer's is a progressive brain disease that affects older adults, slowly destroys their memories and may cause dementia. According to estimates from the National Institutes of Health (NIH), the disease may affect as many as 5.1 million Americans.

22 May 2014

Weight loss at any age in adulthood linked to improved cardiovascular health

Weight loss at any age in adulthood is worthwhile because it could yield long-term heart and vascular benefits, suggests new research published in The Lancet Diabetes & Endocrinology.

21 May 2014

Study: Hearing impairment linked with sleep apnea

Both high and low frequency hearing impairment have been linked with sleep apnea in a new study of nearly 14,000 individuals.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Amsel Medical files 510(K) Pre-Marketing Notification with FDA for Amsel Occluder Device

Amsel Medical Corporation today announced that it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Amsel Occluder Device.

20 May 2014

Low physical activity, heavy use of electronic media linked to increased health risk in children

The Physical Activity and Nutrition in Children Study, PANIC, carried out by the Institute of Biomedicine at the University of Eastern Finland shows that low levels of physical activity combined with heavy use of electronic media and sedentary behaviour are linked to an increased risk for type 2 diabetes and vascular diseases already in 6-8 year-old children.

20 May 2014

Olive oil supplements may counteract adverse cardiovascular effects of exposure to air pollution

Taking olive oil supplements may counteract some of the adverse cardiovascular effects of exposure to air pollution, according to a new study presented at the 2014 American Thoracic Society International Conference.

20 May 2014

Olive oil supplements may counteract adverse cardiovascular effects of air pollution

19 May 2014

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States.

15 May 2014

Boston Scientific to acquire Bayer’s Interventional Division

In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in cash, including fees for transitional services.

15 May 2014

Fourteen businesses receive innovative funding to improve kidney care

NEW ideas and technologies that could prevent kidney disease, allow earlier diagnosis and give patients greater independence are to be developed thanks to an innovative funding competition developed.

From Randox Laboratories Ltd. 15 May 2014

Minimally invasive TAVR procedure saves more lives than open-heart surgery, shows study

For the first time, a minimally invasive transcatheter valve - tested by Baylor Research Institute in Dallas (BRI) - has been shown to save more lives than open-heart surgery, according to new research revealed at the American College of Cardiology's 2014 Scientific Sessions and published in The New England Journal of Medicine.

From Medtronic 14 May 2014

Ill effects of blood pressure variability disputed

The effect of visit-to-visit blood pressure variability on mortality may be partly caused by changes in average values over time, say researchers.

12 May 2014

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Esaote North America announced today that it has received FDA clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound.

12 May 2014

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.

From Bruker BioSpin Group 12 May 2014

New drug approach for safer clean-up of deformed blood vessels in eye

A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.

12 May 2014

Abbott's vascular devices manufacturing facility receives Shingo Prize

Abbott has been awarded the Shingo Prize, an international award for operational excellence, by the Shingo Institute at the Jon M. Huntsman School of Business at Utah State University. Abbott's vascular devices manufacturing facility in Clonmel, Ireland, received the award, recognizing the site's initiative to develop and maintain continuous improvement to achieve operational excellence.

9 May 2014

Vascular News and Research

Consistent glycaemic control wards off diabetic complications

Experts discuss potential advantages of bioresorbable vascular scaffolds at EuroPCR 2014

Researchers identify chemical signals that promote breast cancer metastasis

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Weight loss at any age in adulthood linked to improved cardiovascular health

Study: Hearing impairment linked with sleep apnea

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Amsel Medical files 510(K) Pre-Marketing Notification with FDA for Amsel Occluder Device

Low physical activity, heavy use of electronic media linked to increased health risk in children

Olive oil supplements may counteract adverse cardiovascular effects of exposure to air pollution

Olive oil supplements may counteract adverse cardiovascular effects of air pollution

Inspire Medical Systems completes $40 million Series E financing

Boston Scientific to acquire Bayer’s Interventional Division

Fourteen businesses receive innovative funding to improve kidney care

Minimally invasive TAVR procedure saves more lives than open-heart surgery, shows study

Ill effects of blood pressure variability disputed

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

New drug approach for safer clean-up of deformed blood vessels in eye

Abbott's vascular devices manufacturing facility receives Shingo Prize

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News